Latest dacarbazine Stories
The US Food and Drug Administration has approved two new medicines used to treat the most dangerous form of skin cancer, as well as a genetic test developed alongside those drugs.
Researchers presented findings on Monday at the American Society of Clinical Oncology meeting in Chicago of two experimental treatments that treat advanced melanoma.
Decision Opens New Doors to Long-Awaited Combination Trials WASHINGTON, Aug. 17, 2011 /PRNewswire-USNewswire/ -- Melanoma patients who have long faced a bleak treatment landscape are gaining a new approach for treating the deadliest form of skin cancer.
PARSIPPANY, N.J., Aug.
Second melanoma drug approved this year that improves overall survival SILVER SPRING, Md., Aug. 17, 2011 /PRNewswire-USNewswire/ -- The U.S.
A new study found that people with advanced melanoma who were treated with Bristol-Myers Squibb Co's Yervoy plus chemotherapy lived an average of two months longer than people who got chemotherapy alone.
PARSIPPANY, N.J. and TOKYO, May 11, 2011 /PRNewswire/ -- Daiichi Sankyo announced that applications have been submitted for market approval for vemurafenib (PLX4032/RG7204) for the treatment of metastatic melanoma to the U.S.
-FDA decision on immunotherapy means first new treatment option in more than a decade becoming available- WASHINGTON, March 25, 2011 /PRNewswire-USNewswire/ -- Thirteen years of waiting is now over for melanoma patients.